Eagle Pharmaceuticals, Inc. EGRX
0.25 USD 0.00 (+0.00%)
At closeFeb 5, 2026, 4:00 PM EST
1.50 Day range 1.50
0.001 52-week range 3.94
- YTD
- -64.29%
- 1 year
- -89.36%
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 316.61M | 171.55M | 187.80M | 195.89M | 213.31M | |
| 221.67M | 129.37M | 142.34M | 135.00M | 151.40M | |
| 80.96M | 2.77M | 32.95M | 21.82M | 35.85M | |
| 35.64M | -8.63M | 11.99M | 14.31M | 31.90M | |
| 2.73 | -0.66 | 0.87 | 1.01 | 2.09 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 55.32M | 97.66M | 103.16M | 109.78M | 78.79M | |
| 406.16M | 253.73M | 253.19M | 254.55M | 238.60M | |
| 172.60M | 77.28M | 67.18M | 75.38M | 77.84M | |
| 62.47M | 25.61M | 33.13M | 38.56M | 44.41M | |
| 233.56M | 176.45M | 186.01M | 179.17M | 160.76M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 50.70M | 28.22M | 49.50M | 55.99M | 52.38M | |
| -86.83M | -5.32M | -18.25M | -777.00K | -133.00K | |
| -6.21M | -28.39M | -37.87M | -24.23M | -88.12M | |
| -178.00K | -323.00K | -747.00K | -777.00K | -133.00K | |
| -42.34M | -5.50M | -6.62M | 30.98M | -35.87M |